Research Studies - Cardiovascular

(Study coordinator: Kim Hall)

AIM-HIGH is a cholesterol management program funded by the U.S. National Heart, Lung, and Blood Institute (a part of the U.S. National Institutes of Health) with support from Abbott Laboratories . This study compares how two different FDA-approved treatments that affect cholesterol levels may reduce the risk of heart attacks, stroke and other heart-related complications. The two FDA-approved treatments used in AIM-HIGH are:

* Simvastatin (or Zocor®) taken alone
* Simvastatin taken with extended-release niacin (Niaspan®)

The AIM-HIGH cholesterol program enables patients to receive cholesterol medications and access to medical experts at no cost to them or their insurers. Medications, lab tests and office visits related to the study are provided at no cost.